Status:
COMPLETED
Effect of Biologic Therapy on Surgical Outcomes for Perforated Crohn's Patients
Lead Sponsor:
Zagazig University
Conditions:
Crohn Disease
Eligibility:
All Genders
18+ years
Brief Summary
crohn's disease patients who present by intestinal perforation as the first presentation are hard to deal with. Surgical techniques as anastmosis or diversion stoma and active course of the disease ma...
Eligibility Criteria
Inclusion
- patients at or above 18 years old
- patients with perforated bowel diagnosed as Crohn's disease at presentation underwent surgery
Exclusion
- patients less than 18 years old
- well known Crohn's disease patients on medical treatment
- associated bowel disease as malignancy and diverticulosis.
Key Trial Info
Start Date :
July 9 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 9 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06511921
Start Date
July 9 2015
End Date
July 9 2025
Last Update
August 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zagazig University Hospitals
Zagazig, Egypt, 44519